Related by context. Frequent words. (Click for all words.) 73 RTOG 67 EORTC 66 SWOG 65 NSABP 64 National Surgical Adjuvant 64 Cooperative Oncology 62 randomized Phase III 61 placebo controlled clinical 60 multicenter randomized 60 multicentre 59 multicenter study 58 multicenter 58 HER2 positive metastatic breast 58 prospective observational 58 Solid Tumors 58 prospective randomized controlled 58 TRITON TIMI 58 Amrubicin 57 PRECiSE 57 Thoracic Oncology 57 neoadjuvant 56 J Clin Oncol 56 ECOG 56 retrospective cohort study 56 Acute Myocardial Infarction 56 chemoradiotherapy 55 randomized controlled clinical 55 MSKCC 55 Phase III randomized 54 phase IIa 54 substudy 54 double blinded placebo 54 #:#-# [031] 54 Meta Analysis 54 prospective randomized 54 multicenter clinical 54 subgroup analyzes 54 SPIRIT III 54 multicenter randomized double 54 Clinical Outcomes 54 ASCO Annual Meeting 54 randomized clinical 53 placebo controlled randomized 53 Lung Transplantation 53 Phase 2a trial 53 active comparator 53 Phase Ib 53 immunohistochemical 53 noninferiority 53 HGS ETR1 53 ACC AHA 53 nab paclitaxel 53 relapsed refractory multiple myeloma 53 AASLD 53 randomized placebo controlled 53 dose escalation trial 53 label dose escalation 53 phase IIb 52 Arch Intern Med 52 Pivotal Trial 52 Pharmacokinetic 52 PROPEL 52 Duke Comprehensive Cancer 52 Randomized Controlled Trial 52 Breast Cancer Symposium 52 Stroke NINDS 52 COPAXONE R 52 Azedra 52 Chronic Lymphocytic Leukemia 52 End Results SEER 52 label multicenter 52 unblinded 52 neoadjuvant chemotherapy 52 randomized controlled 52 Phase 2b study 52 Myocardial Infarction 52 Atherosclerosis Risk 52 Phase III pivotal 52 aflibercept 52 dose escalation study 52 Phase 1b 52 randomized 52 Liver Transplantation 52 CATIE 52 Phase 2a clinical 52 antitumor activity 52 blinded placebo controlled 52 chemoradiation 52 dose escalation 52 histopathological 52 glufosfamide 51 LymphoStat B 51 ClinicalTrials.gov 51 Cloretazine R VNP#M 51 talabostat 51 invasive bladder 51 J Am Coll 51 cytogenetic response 51 histologically 51 Neuro Oncology 51 Pharmacoeconomics